rs143396390

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_030665.4(RAI1):​c.4043C>T​(p.Ala1348Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000505 in 1,613,728 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A1348A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00053 ( 0 hom. )

Consequence

RAI1
NM_030665.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -0.497

Publications

5 publications found
Variant links:
Genes affected
RAI1 (HGNC:9834): (retinoic acid induced 1) This gene is located within the Smith-Magenis syndrome region on chromosome 17. It is highly similar to its mouse counterpart and is expressed at high levels mainly in neuronal tissues. The protein encoded by this gene includes a polymorphic polyglutamine tract in the N-terminal domain. Expression of the mouse counterpart in neurons is induced by retinoic acid. This gene is associated with both the severity of the phenotype and the response to medication in schizophrenic patients. [provided by RefSeq, Jul 2008]
RAI1 Gene-Disease associations (from GenCC):
  • Smith-Magenis syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet
  • Potocki-Lupski syndrome
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.02567339).
BP6
Variant 17-17796991-C-T is Benign according to our data. Variant chr17-17796991-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 196549.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000237 (36/152184) while in subpopulation NFE AF = 0.000441 (30/68032). AF 95% confidence interval is 0.000317. There are 0 homozygotes in GnomAd4. There are 19 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 36 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030665.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAI1
NM_030665.4
MANE Select
c.4043C>Tp.Ala1348Val
missense
Exon 3 of 6NP_109590.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
RAI1
ENST00000353383.6
TSL:1 MANE Select
c.4043C>Tp.Ala1348Val
missense
Exon 3 of 6ENSP00000323074.4Q7Z5J4-1
RAI1
ENST00000918590.1
c.4043C>Tp.Ala1348Val
missense
Exon 2 of 5ENSP00000588649.1
RAI1
ENST00000955422.1
c.4043C>Tp.Ala1348Val
missense
Exon 3 of 6ENSP00000625481.1

Frequencies

GnomAD3 genomes
AF:
0.000237
AC:
36
AN:
152184
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000187
AC:
47
AN:
251260
AF XY:
0.000265
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000387
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000533
AC:
779
AN:
1461544
Hom.:
0
Cov.:
37
AF XY:
0.000539
AC XY:
392
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.0000377
AC:
2
AN:
53070
Middle Eastern (MID)
AF:
0.000173
AC:
1
AN:
5768
European-Non Finnish (NFE)
AF:
0.000683
AC:
759
AN:
1112012
Other (OTH)
AF:
0.000199
AC:
12
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
50
101
151
202
252
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000237
AC:
36
AN:
152184
Hom.:
0
Cov.:
33
AF XY:
0.000256
AC XY:
19
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41452
American (AMR)
AF:
0.0000654
AC:
1
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000441
AC:
30
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000461
Hom.:
0
Bravo
AF:
0.000264
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.000491
EpiControl
AF:
0.000474

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
5
not provided (6)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)
-
-
1
RAI1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.21
DANN
Benign
0.88
DEOGEN2
Benign
0.068
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.037
N
LIST_S2
Benign
0.71
T
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.026
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.83
N
PhyloP100
-0.50
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.68
N
REVEL
Benign
0.17
Sift
Benign
0.93
T
Sift4G
Benign
0.20
T
Polyphen
0.0010
B
Vest4
0.031
MVP
0.17
MPC
0.27
ClinPred
0.015
T
GERP RS
-3.8
Varity_R
0.015
gMVP
0.14
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143396390; hg19: chr17-17700305; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.